📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
AGI Infra Secures RERA Registration for 360-Unit Urbana Square Commercial Project
AGI Infra Limited has successfully obtained RERA registration for its commercial project, Urbana Square, located in Jalandhar, Punjab. The project is a significant addition to the company's portfolio, featuring a total of 360 units divided into 142 commercial shops and 218 office spaces. This regulatory approval is valid until September 1, 2027, and allows the company to officially commence sales and marketing. The project is expected to contribute positively to the company's revenue and profitability in the coming quarters.
Key Highlights
Received RERA registration (PBRERA-JAL33-PC0397) for the Urbana Square commercial project in Jalandhar.
The project consists of 360 total units, including 142 commercial shops and 218 office spaces.
The regulatory approval is valid for a period ending September 1, 2027.
Enables the company to increase revenue and profits through the sale of these commercial units.
💼 Action for Investors
Investors should track the sales progress and booking velocity of the Urbana Square project as it will be a primary driver for cash flow and earnings growth. The timely receipt of RERA registration mitigates regulatory execution risk for this specific development.
Sagility Limited Q2 FY25 PAT Surges 69% QoQ to ₹2,508 Million
Sagility Limited has submitted its machine-readable financial results for the quarter and half-year ended September 30, 2025. The company reported a consolidated revenue of ₹16,584.99 million for Q2 FY25, marking a 7.7% growth over the previous quarter. Net profit for the quarter saw a substantial jump to ₹2,508.26 million compared to ₹1,485.59 million in Q1 FY25. The results reflect strong operational performance and sequential growth in the healthcare services segment.
Key Highlights
Consolidated revenue from operations grew 7.7% QoQ to ₹16,584.99 million in Q2 FY25.
Net profit (PAT) for the quarter stood at ₹2,508.26 million, a 68.8% increase over Q1 FY25.
Half-year (H1 FY25) revenue reached ₹31,974.41 million with a total PAT of ₹3,993.85 million.
Basic and Diluted EPS improved to ₹0.53 for the quarter from ₹0.32 in the preceding quarter.
Total assets as of September 30, 2025, increased to ₹1,15,272.97 million, with equity at ₹88,944.57 million.
💼 Action for Investors
Investors should note the strong sequential growth in profitability and revenue, which indicates positive business momentum. The stock remains a key play in the healthcare BPM space, though investors should monitor the high goodwill component on the balance sheet.